Next 10 |
home / stock / alvow / alvow news
2024-03-21 14:58:03 ET Alvotech (ALVO) Q4 2023 Earnings Conference Call March 21, 2024 08:00 ET Company Participants Benedikt Stefansson - Senior Director of Investor Relations & Global Communications Robert Wessman - Chairman & Chief Executive Officer An...
2023-11-29 10:13:14 ET Alvotech (ALVO) Q3 2023 Earnings Conference Call November 29, 2023, 08:00 AM ET Company Participants Benedikt Stefansson - Senior Director of IR and Global Communications Robert Wessman - Chairman and CEO Anil Okay - Chief Commercial Office...
2023-09-02 09:00:00 ET Summary The biosimilar drug market is projected to grow at a rate of ~18% from 2023-2028, attracting significant investment. Alvotech is positioned within the biosimilars value chain and has the potential to generate value with its pipeline assets. The c...
2023-08-31 14:32:10 ET Alvotech (ALVO) Q2 2023 Earnings Conference Call August 31, 2023 08:00 AM ET Company Participants Benedikt Stefansson - Director of IR & Global Communications Robert Wessman - Chairman & CEO Anil Okay - Chief Commercial Officer ...
2023-07-06 11:00:00 ET Summary Alphyn Capital Management LLC (“ACML”) is a registered investment advisor in New York. We help clients invest in high quality public companies to both preserve and grow their wealth over the long term. Compliance advisors recommend with...
2023-05-19 14:15:24 ET Alvotech (ALVO) Q1 2023 Earnings Conference Call May 19, 2023, 8:00 AM ET Company Participants Benedikt Stefansson - Director of Investor Relations and Global Communications Robert Wessman - Chairman and Chief Executive Officer Anil Okay - ...
2023-05-08 07:00:00 ET Summary Fuji Pharma Co., Ltd. is mainly a generics pharma company focused on the less volatile Japanese generics market, whose market structure is associated with less regulatory risks, competition, and generics profitability risks. Its generics focus is a p...
2023-03-06 11:44:01 ET Alvotech (ALVO) Q4 2022 Results Conference Call March 02, 2023 8:00 AM ET Company Participants Benedikt Stefansson - Director of Investor Relations Robert Wessman - Chairman and CEO Anil Okay - Chief Commercial Officer Hafrun Fridriksdo...
Summary Alphyn Capital Management LLC (“ACML”) is a registered investment advisor in New York. We help clients invest in high quality public companies to both preserve and grow their wealth over the long-term. The Master Account returned 20.4% net in Q4 2022 vs 7.6% for th...
Summary It’s among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie. Several drugmakers are expected to begin offering biosimilar ver...